DOI: 10.12809/hkmj187547
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
LETTER TO THE EDITOR
Population-based mammography screening programme should
be rigorously evaluated
TH Lam, MD
School of Public Health, Li Ka Shing Faculty of
Medicine, The University of Hong Kong, Pokfulam, Hong Kong
Corresponding author: Dr Regina Ching (regina_ching@dh.gov.hk)
To the Editor–Screening programmes must be
rigorously evaluated using epidemiological principles. Arguments put
forward by Chow1 provide only part
of the picture.
An implicit assumption underlying the concept of
screening is that detection before symptoms develop leads to a more
favourable prognosis because earlier treatment is more effective than
treatment started later. This assumption has intuitive appeal but the
concept of screening is not as straightforward as it may appear. Any
standard textbook of epidemiology will caution that issues such as
appropriateness and evaluation of the screening test, subsequent diagnosis
and management, and associated risks or costs, need to be rigorously
considered to achieve the best value in population health terms.
Hong Kong has never established a population-based
breast cancer screening programme. The Cancer Expert Working Group on
Cancer Prevention and Screening (CEWG) regularly revisits the literature
and has never claimed that screening is of little value. Neither has it
ruled in or out the possibility of breast cancer screening for local women
at average risk. The CEWG states that there is insufficient evidence to
recommend for or against population-based mammography screening for local
asymptomatic women at average risk. This is a prudent approach when
countries like the United Kingdom, Switzerland, and France have a
decreased passion for similar mass screening programmes.2 3 4
Women and doctors alike should be aware of the
potential risks and benefits of breast cancer screening. For women whose
risk level is average or low but who nevertheless consider undergoing the
procedure, the doctor has a duty of care to explain not only the pros but
also the cons of the procedure, including the possibility of a
false-positive result, overdiagnosis, and overtreatment. Development of a
validated risk prediction tool for the local population, which has been
commissioned by the Government and is ongoing, can be used to guide
screening decisions and enable women and clinicians to make an informed
choice.
Of equal importance is the need for all stakeholder
groups to encourage women to adopt healthy lifestyle habits that protect
against breast cancer development, such as avoiding alcohol consumption,
engaging in moderate and vigorous physical activity, maintaining a healthy
body weight and waist circumference, and breastfeeding for as long as
possible5; as well as raising
breast awareness and literacy so that women seek medical attention as soon
as they notice any unusual breast changes.
Declaration
The author has no conflicts of interest to
disclose.
References
1. Chow LC. Is now the right time to
abolish breast cancer screening in Hong Kong? Hong Kong Med J
2018;24:216-7. Crossref
2. Marmot MG, Altman DG, Cameron DA, Dewar
JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer
screening: an independent review. Br J Cancer 2013;108:2205-40. Crossref
3. Biller-Andorno N, Jüni P. Abolishing
mammography screening programs? A view from the Swiss Medical Board. N
Engl J Med 2014;370:1965-7. Crossref
4. Barratt A, Jørgensen KJ, Autier P.
Reform of the national screening mammography program in France. JAMA
Intern Med 2018;178:177-8. Crossref
5. World Cancer Research Fund. Summary of
conclusions. Available from:
https://www.wcrf.org/sites/default/files/Matrix-for-all-cancers-A3.pdf.
Accessed 10 Jul 2018.